Understanding how heart conditions affect tolerance to rapid heart rates
Official title: Coronary Epicardial and Microcirculatory Determinants of Ventricular Tachycardia Tolerability
Run by Imperial College London · NCT05841199 · Data updated 2026-11-12
This study is testing how well people with heart conditions, especially those with coronary artery disease, can handle fast heart rates and whether treating their condition with stents can help them tolerate it better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | August 1, 2023 |
| Main results expected | June 2, 2026 |
| Study ends | June 2, 2026 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT05841199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients referred for coronary angiography or angioplasty who can provide valid consent.
✕Probably not a fit
Patients with unstable coronary artery disease, severe heart valve disease, or severe heart failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the factors that influence how well patients tolerate ventricular tachycardia (VT), particularly focusing on the impact of coronary artery disease. Participants undergoing coronary angiograms or angioplasty will have their blood pressure, coronary pressure, and flow measured during induced rapid heart rates. The study seeks to determine whether treating coronary artery disease with stents can improve VT tolerability. By identifying these factors, the research could help tailor patient management and potentially reduce the need for implantable cardioverter defibrillators (ICDs).
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with ventricular tachycardia, potentially reducing reliance on ICDs.
How similar studies have gone: While this approach is observational and may build on existing knowledge, it addresses a specific gap in understanding VT tolerability, making it a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to give valid consent * Referred for coronary angiography or coronary angioplasty * Suitable for percutaneous physiological interrogation and PCI when clinically indicated Exclusion Criteria: * Unable to give valid consent * Pregnant or breastfeeding women * Unstable coronary artery disease (acute coronary syndrome) * Severe multivessel coronary artery disease suitable for coronary artery bypass grafting * Severe heart valve disease * Severe (NYHA IV) heart failure
Where it's running
-
Imperial College NHS Foundation Trust
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Ricardo Petraco — Senior Clinical Research Fellow
- Study coordinator: Rahul Bahl
- Email: r.bahl@imperial.ac.uk
- Phone: +44 20 7594 1093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for monitoring heart conditions
This study is collecting health information from people with heart symptoms to see if it can help doctors catch heart problems earlier and understand them better.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
-
Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries
This trial tests whether bypass surgery (CABG) or stents (PCI) lead to better survival, fewer major heart problems, and improved quality of life for adults with reduced left ventricular function (LVEF ≤40%) and multivessel coronary disease.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.